Northern Trust’s Verrica Pharmaceuticals VRCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$110K Sell
20,740
-22,735
-52% -$121K ﹤0.01% 4090
2025
Q1
$192K Buy
43,475
+21,772
+100% +$96.3K ﹤0.01% 3957
2024
Q4
$152K Sell
21,703
-207
-0.9% -$1.45K ﹤0.01% 4067
2024
Q3
$318K Buy
21,910
+2,842
+15% +$41.2K ﹤0.01% 3716
2024
Q2
$1.39M Sell
19,068
-804
-4% -$58.6K ﹤0.01% 3095
2024
Q1
$1.18M Sell
19,872
-16
-0.1% -$947 ﹤0.01% 3242
2023
Q4
$1.46M Buy
19,888
+1,140
+6% +$83.4K ﹤0.01% 3151
2023
Q3
$728K Sell
18,748
-168
-0.9% -$6.53K ﹤0.01% 3396
2023
Q2
$1.09M Buy
18,916
+13,774
+268% +$795K ﹤0.01% 3325
2023
Q1
$334K Buy
5,142
+361
+8% +$23.5K ﹤0.01% 3616
2022
Q4
$131K Sell
4,781
-34
-0.7% -$935 ﹤0.01% 4011
2022
Q3
$141K Buy
4,815
+670
+16% +$19.6K ﹤0.01% 4006
2022
Q2
$80K Sell
4,145
-9,451
-70% -$182K ﹤0.01% 4263
2022
Q1
$1.1M Sell
13,596
-388
-3% -$31.5K ﹤0.01% 3376
2021
Q4
$1.28M Sell
13,984
-61
-0.4% -$5.59K ﹤0.01% 3443
2021
Q3
$1.76M Sell
14,045
-647
-4% -$80.9K ﹤0.01% 3352
2021
Q2
$1.66M Sell
14,692
-500
-3% -$56.5K ﹤0.01% 3406
2021
Q1
$2.3M Sell
15,192
-2,595
-15% -$393K ﹤0.01% 3164
2020
Q4
$2.05M Sell
17,787
-974
-5% -$112K ﹤0.01% 3184
2020
Q3
$1.45M Buy
18,761
+6,915
+58% +$535K ﹤0.01% 3213
2020
Q2
$1.3M Sell
11,846
-3,320
-22% -$365K ﹤0.01% 3250
2020
Q1
$1.66M Buy
15,166
+1,052
+7% +$115K ﹤0.01% 2961
2019
Q4
$2.24M Buy
14,114
+480
+4% +$76.3K ﹤0.01% 3056
2019
Q3
$2.01M Buy
13,634
+2,508
+23% +$370K ﹤0.01% 3103
2019
Q2
$1.29M Buy
11,126
+405
+4% +$47.1K ﹤0.01% 3271
2019
Q1
$1.16M Buy
10,721
+4,018
+60% +$434K ﹤0.01% 3307
2018
Q4
$546K Buy
6,703
+469
+8% +$38.2K ﹤0.01% 3533
2018
Q3
$1.01M Buy
+6,234
New +$1.01M ﹤0.01% 3464